Literature DB >> 6809907

Thyrotrophin-producing pituitary adenomas.

S A Hill, J M Falko, C B Wilson, W E Hunt.   

Abstract

Hyperthyroidism due to thyrotrophin (TSH)-secreting pituitary tumors is rare. Four cases are described, with the features that allow preoperative diagnosis. In all the patients, thyroid hormone production was consistently elevated despite antithyroid therapy, and TSH levels were inappropriately elevated. All patients were treated with both surgery and irradiation. Each patient had recurrent tumor with suprasellar, intrasphenoidal, or intraorbital spread. The combination of a recurrent, aggressive tumor complicated by thyrotoxicosis makes this a complex and difficult surgical problem.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809907     DOI: 10.3171/jns.1982.57.4.0515

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Surgical management of thyrotropin-secreting pituitary adenomas.

Authors:  M Losa; P Mortini; A Franzin; R Barzaghi; C Mandelli; M Giovanelli
Journal:  Pituitary       Date:  1999-08       Impact factor: 4.107

Review 2.  Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.

Authors:  N Sanno; A Teramoto; R Y Osamura
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

Review 3.  Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Authors:  P E Battershill; S P Clissold
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

4.  Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma of the thyroid--a case report and surgical strategy.

Authors:  S Ohta; S Nishizawa; Y Oki; H Namba
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

5.  A pituitary thyrotrophinoma causing thyrotoxicosis and amenorrhoea/galactorrhoea: studies of alpha-subunit in the tumour and in blood.

Authors:  R A Fisken; B A Walker; P H Buxton; R V Jeffreys; L J Hipkin; M C White
Journal:  J R Soc Med       Date:  1989-05       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.